REPRODUCTIVE DISORDERS AND THEIR PATHOGENETIC MECHANISMS IN WOMEN WITH HIV
https://doi.org/10.22328/2077-9828-2019-11-4-20-29
Abstract
Background. Highly active antiretroviral therapy (ART) has increased the life expectancy of people living with the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). Advances in scientific knowledge and, in particular, in the management of an HIV-infected pregnant woman have also reduced the risk of mother-to-child transmission of HIV. Aims. Consider the current problems of gynecological and reproductive health disorders and the pathophysiological aspects of these disorders in HIV-infected women. Methods. Review of Russian and international scientific publications related to gynecology, reproductive health and HIV infection from indexed online journals and relevant websites using Pubmed and Google search from 1990 to March 2019. Results. In recent years, the proportion of HIV-infected women has increased and the role of sexual transmission of infection has increased, as well as the active involvement of women of reproductive age in the HIV epidemic. In HIV-infected pregnant women who did not receive HAART, the frequency of obstetric complications, labor and adverse outcomes in children is increased. HIV infection can reduce the fertility of women at any stage of the disease, marked violations of the menstrual cycle and ovulation, reduced ovarian reserve and the quality of oocytes. In HIV-infected patients, weight loss and dystrophy, impaired thyroid function, adrenal glands and hypogonadism are recorded. Violations of the menstrual, ovulatory function can occur for a variety of reasons that are not directly related to their illness, but to multiple stressors. HIV-positive women suffer from increased frequency and severity of pelvic infections and precancerous and malignant lesions of the cervix. Conclusions. Gynecological, reproductive needs, as well as the specifics of monitoring an HIV-positive woman are not sufficiently assessed, are not optimal and are largely ignored, which can negatively affect their quality of life and efforts to combat the HIV epidemic.
About the Authors
O. Ya. Leshchenko
Scientific Centre of Family Health and Human Reproduction Problems
Russian Federation
Irkutsk, Russia
Russian Federation
Irkutsk, Russia
E. V. Genich
Scientific Centre of Family Health and Human Reproduction Problems
Russian Federation
Irkutsk, Russia
Russian Federation
Irkutsk, Russia
References
1. Федеральный Центр СПИД, Официальная статистика по ВИЧ в России (обновляемая, аналитика, графики). https://spid-vichzppp.ru/statistika/epidemiya-vich-spida-v-rossii-2017.html. [Federal AIDS Center, Official statistics on HIV in Russia (updated, Analytics, graphs) (In Russ.)].
2. Belyakov N.A., Vinogradova T.N. Sexual path of HIV transmission in the development of the epidemic. HIV infection and immunosuppression, 2011, No. 3 (4), рр. 7–19 (In Russ.).
3. National Association of People Living With HIV/AIDS 2008. AIDS 2008: The Swiss Statement — the debate continues, 2009. Available at http://napwa.org.au/pl/2008/09/aids-2008-the-swiss-statement-the-debate-continues.
4. Ogarkov O.B., Ebers A., Zhdanova S. Administrative interventions associated with increased initiation on antiretroviral therapy in Irkutsk // Siberia Public Health Action. 2016. No. 6 (4). Р. 252–254. DOI: 10.5588/pha.16.0050.
5. Kuete M., Yuan Hong Fang, Tchoua Kemayou A.L., Songo E.A., Yang F., Ma Xiu Lan, Xiong Cheng Liang, Zhang Hui Ping. Scale up use of family planning services to prevent maternal transmission of HIV among discordant couples: a cross-sectional study within a resource-limited setting // Patient Prefer Adherence. 2016. No. 10. Р. 1967–1977. DOI: 10.2147/PPA.S105624.
6. Leshchenko O., Genich E. Sex behavior and reproductive attitudes of HIV-positive men and women // Maturitas. 2019. No. 124. Р. 152–153. DOI: https://doi.org/10.1016/j.maturitas.2019.04.121.
7. Kushnir V., Lewis W. Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals // Fertil Steril. 2011. No. 96 (3). Р. 546–553. DOI: 10.1016/j.fertnstert.2011.05.094.
8. Heysell S.K., Ogarkov O.B., Zhdanova S. Undertreated hiv and drug-resistant tuberculosis at a referral hospital in Irkutsk // Siberia International Journal of Tuberculosis and Lung Disease. 2016. No. 20 (2). Р. 187–192. DOI: 10.5588/ijtld.14.0961.
9. Nguyen R.H., Gange S.J. Reduced fertility among HIV-infected women associated with viral load in Rakai district, Uganda // Int. J. STD AIDS. 2006. No. 17 (12). Р. 842–846. DOI: 10.1258/095646206779307586.
10. Zaid D., Greenman Y. Human Immunodeficiency Virus Infection and the Endocrine System // Endocrinol. Metab. (Seoul). 2019. Jun; No. 34 (2). Р. 95–105. DOI: 10.3803/EnM.2019.34.2.95.
11. Yalamanchi S., Dobs A., Greenblatt R.M. Gonadal function and reproductive health in women with HIV infection // Endocrinol. Metab. Clin. North Am. 2014. Sep; No. 43 (3). Р. 731–741. DOI: 10.1016/j.ecl.2014.05.00212.
12. Kolesnikova L.I., Kolesnikov S.I., Darenskaya M.A., Grebenkina L.A., Timofeeva E.V., Leshchenko O.Ya. Evaluation of the pro- and antioxidant status of women with HIV or coinfection // Terapevticheskii arkhiv. 2016. No. 88 (11). Р. 17–21. DOI: 10.17116/terarkh2016881117-21.
13. Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018. Davies N.E.C.G., Ashford G., Bekker L. G., Chandiwana N., Cooper D., Dyer S.J., Jankelowitz L., Mhlongo O., Mnyani C.N., Mulaudzi M.B., Moorhouse M., Myer L., Patel M., Pleaner M., Ramos T., Rees H., Schwartz S., Smit J., van Zyl D.S. // South Afr J HIV Med. 2018. No. 19 (1). Р. 915. Published online 2018 Oct 18. DOI: 10.4102/sajhivmed.v19i1.915.
14. Harlow S.C., Schuman P.M. Effect of HIV infection on menstrual cycle length // AIDS. 2000. No. 24 (1). Р. 68–75. https://www.ncbi.nlm.nih.gov/pubmed/10877498.
15. Watts D.H., Spino C. Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/μl and below 100 cells/μl // J. AIDS. 1999. No. 20 (5). Р. 455–462. DOI: 10.1097/00042560-199904150-00007.
16. Fraile P.A. Patient with testosterone deficit syndrome and HIV infection // Arch. Esp. Urol. 2013. No. 66 (7) Р. 696–702.
17. Mazer N.A. Testosterone deficiency in women: etiologies, diagnosis, and emerging treatments // Int. J. Fertil. 2002. No. 47 (2). Р. 77–86. https://www.ncbi.nlm.nih.gov/pubmed/11991434
18. Choi H.H., Gray P.B. Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss // J. Clin. Endocrinol. Metab. 2005. No. 90 (3). Р. 1531–1541. DOI: 10.1210/jc.2004–1677.
19. Greenblatt R., Ameli N. Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women // J. Infect. Dis. 2000. No. 181. Р. 181–190. DOI: 10.1086/315207.
20. Clark R.A., Mulligan K. Frequency of Anovulation and Early Menopause among Women Enrolled in Selected Adult AIDS Clinical Trials Group Studies // Journal of Infectious Diseases. 2001. No. 184. Р. 1325–1327. https://doi.org/10.1086/323999
21. Musaret J., Amneris E. L. Prevalence of Human Papillomavirus Genotypes and Related Abnormalities of Cervical Cytological Results among HIV-1-Infected Women in Rochester. New York // JID. 2006. No. 194. Р. 428–434. https://doi.org/10.1086/505876.
22. Firnhaber C., Pettifor A. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa // Cancer Causes Control. 2010. No. 21 (3). Р. 433–443. DOI: 10.1007/s10552-009-9475-z.
23. Sadhana M. Gupta, Jayanti Mania-Pramanik. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis // J. Biomed Sci. 2019. No. 26. Р. 28. Published online. 2019. Apr. 23. DOI: 10.1186/s12929-019-0520-2.
24. Leshchenko O., Belyaeva E., Yershova O., Atalyan A., Timofeeva E. The frequency of human papilloma virus in women of reproductive age with HIV infection // Journal of Lower Genital Tract Disease. 2017. No. 21. Р. 39–40.
25. Soncini E., Zoncada A. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy // Acta Biomed. 2007. No. 78 (1). Р. 36–40. https://pdfs.semanticscholar.org/056f/7eaafbbd12f495f4adff64bc6eeef1a7a543.pdf.
26. Calvert С., Ronsmans С. HIV and the Risk of Direct Obstetric Complications: A Systematic Review and Meta-Analysis // PLoS. One. 2013. No 8 (10). e74848. Published online 2013 Oct 4. DOI: 10.1371/journal.pone.0074848.
27. Pitsos M., Skurnick J. Association of pathologic diagnoses with clinical findings in chronic endometritis // J. Reprod. Med. 2009. No 54 (6). Р. 373–377. https://www.ncbi.nlm.nih.gov/pubmed/19639927.
28. Mugo N.R., Kiehlbauch J.A. Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis. Obstet. Gynecol. 2006. No. 107 (4). Р. 807–812. DOI: 10.1097/01.AOG.0000207597.70524.e8.
29. Sebitloane M.H. HIV and gynaecological infections // Best Pract. Res. Clin. Obstet. Gynaecol. 2005. No. 19 (2). Р. 231–241.
30. Oliveira P.M., Mascarenhas R.E., Ferrer S.R. Vaginal infections in human immunodeficiency virus-infected women // Rev. Bras. Ginecol. Obstet. 2008. No. 30 (3). Р. 121–126. https://www.researchgate.net/publication/23789436_Vaginal_infections_in_human_immunodeficiency_virusinfected_women.
31. Watts D.H., Springer G., Minkoff H. Occurrence of vaginal infections among HIV-Infected and high-risk HIV-uninfected women: longitudinal findings of the Women’s Interagency HIV Study // J. AIDS. 2006. No. 43. Р. 161–168. DOI: 10.1097/01.qai.0000242448.90026.13.
32. Kibiriqe D., Ssekitoleko R. Endocrine and metabolic abnormalities among HIV-infected patients: a current review // Int. J. STD AIDS. 2013. No. 24. Р. 603–611. DOI: 10.1177/0956462413479895.
33. Zapanti E., Terzidis K., Chrouso G. Dysfuntion of the hypothalamic pituitary adrenal axis in HIV infection and disease // Hormones. 2008. No. 7 (3). Р. 205–216. DOI: 10.14310/horm.2002.1200.
34. Bartlett D., Gallant D. Clinical aspects of HIV infection. Baltimore, MD: Publishing business group J. Hopkin, 2006. 455 р. (In Russ.).
35. Leshchenko O., Genich E. Susceptible hormones in women with HIV‐infection and displeasure // BJOG: An International Journal of Obstetrics & Gynaecology. 2019. No. 126. Р. 217–224. DOI:10.1111/1471-0528.20_15703.
36. Leshchenko O., Marianian A., Timofeeva E., Atalyan A., Balochova T. HIV infection in men and women of reproductive age // Alcoholism: Clinical and Experimental Research. 2017. No. 41 (6). 150A.
37. Dillon J.S. Dehydroepiandrosterone, dehydroepiandrosterone sulfate andrelated steroids: their role in inflammatory, allergic and immunological disorders // Curr. Drug Targets Inflamm Allergy. 2005. No. 4. Р. 377–385.
38. Nassoro D.D., Mkhoi M.L., Sabi I., Meremo A.J., Lawala P.S., Mwakyula I.H. Adrenal Insufficiency: A Forgotten Diagnosis in HIV/AIDS Patients in Developing Countries // Int. J. Endocrinol. 2019; 2019. 2342857. Published online 2019 Jun. 23. DOI: 10.1155/2019/2342857.
39. Shashidhar P.K., Shashikala G.V. Low dose adrenocorticotropic hormone test and adrenal insufficiency in critically ill acquired immunodeficiency syndrome patients // Indian J. Endocrinol. Metab. 2012. No. 16. Р. 389–394. DOI: 10.4103/2230–8210.95680.
40. Levy D.E. HIV and the pathogenesis of AIDS. Moscow: Scientific World, 2010. 736 р. (In Russ.).
41. Barlow-Mosha L., Eckard A.R., McComsey G.A., Musoke P.M. Metabolic complications and treatment of perinatally HIV-infected children and adolescents // J. Int. AIDS Soc. 2013. No. 16 (1). Р. 18600. Published online 2013 Jun 18. DOI: 10.7448/IAS.16.1.18600.
42. Brown T.T. The effects of HIV-1 infection on endocrine organs // Best Pract. Res. Clin. Endocrinol. Metab. 2011. No. 25. Р. 414. DOI: 10.1016/j.beem.2011.04.005.
43. Sanjay K., Hamby S. Human immunodeficiency virus and the endocrine system // Indian J. Endocrinol. Metab. 2011. No. 15 (4). Р. 231–233. DOI: 10.4103/2230–8210.85566.
44. Yalamanchi S., Dobs A., Greenblatt R.M. Gonadal function and reproductive health in women with human immunodeficiency virus infection // Endocrinol. Metab. Clin. North Am. 2014. No. 43 (3). Р. 731–741. DOI: 10.1016/j.ecl.2014.05.002.
45. Varthakavi P.K. Thyroid Dysfunction in HIV-AIDS // JAPI. 2009. No. 57. Р. 503–504.
46. Sinha U., Sengupta N. Human immunodeficiency virus endocrinopathy // Indian J. Endocrinol. Metab. 2011; 15 (4). Р. 251–260. DOI: 10.4103/2230-8210.85574.
47. Zaid D., Greenman Y. Human Immunodeficiency Virus Infection and the Endocrine System // Endocrinol. Metab. (Seoul). 2019. Jun; No 34 (2). Р. 95–105. Published online 2019 May 20. DOI: 10.3803/EnM.2019.34.2.95.
48. Ohl J., Partisani M. Alterations of ovarian reserve tests in Human Immunodeficiency Virus (HIV)-infected women // Gynécologie Obstétrique & Fertilité. 2010. Р. 313–317. DOI: 10.1016/j.gyobfe.2009.07.019.
49. Willems N., Lemoine C., Liesnard C. Is ovarian function impaired in HIV patients? A clinical pilot study in Burkina Faso // Rev Med Brux. 2013. No. 34 (5). Р. 397–404. https://www.ncbi.nlm.nih.gov/pubmed/24303653.
50. Scherzer R., Bacchetti P. Impact of CD4+ lymphocytes and HIV infection on Anti-Müllerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women // Am. J. Reprod. Immunol. 2015. No. 73 (3). Р. 273–284. DOI: 10.1111/aji.12332.
Review
For citations:
Leshchenko O.Ya., Genich E.V. REPRODUCTIVE DISORDERS AND THEIR PATHOGENETIC MECHANISMS IN WOMEN WITH HIV. HIV Infection and Immunosuppressive Disorders. 2019;11(4):20-29. (In Russ.) https://doi.org/10.22328/2077-9828-2019-11-4-20-29
Views:
3292
.png)
Email this article 